Researchers have identified a key weakness in acute myeloid leukemia, offering a promising new strategy to delay the ...

Acute myeloid leukemia (AML) is classified as primary, or “de novo,” if it develops in people without a history of another blood disorder or cancer treatment. Secondary AML either develops ...

San Francisco–based Ossium Health has carried out three transplants for cancer patients using stem cells from deceased donors ...

Thanks to Joanna from Poland, I have no measurable leukemia. Getting college-age kids to join the bone-marrow donor registry ...

A patient with acute myeloid leukemia received a bone marrow transplant from a deceased donor, achieved engraftment, and has ...

Research from the Icahn School of Medicine at Mount Sinai provides new insights into acute myeloid leukemia (AML) and its ...

What Do Your Blood Cells Do?Leukemia develops in the blood cells produced by your bone marrow. These include: Red blood cells (RBCs), which deliver oxygen throughout the bodyWhite blood cells (WBCs), ...

Researchers have identified a key weakness in acute myeloid leukaemia, offering a promising new strategy to delay the ...

Syndax Pharmaceuticals (Nasdaq: SNDX) has announced that its Phase II AUGMENT-101 trial of experimental drug revumenib ...

Data presentations will focus on the company's clinical and preclinical studies in IDH-mutated acute myeloid leukemia (AML ..

Syros saw a 23.8% complete response rate in people who received the combination ... Investors, already burnt by setbacks such ...

As word of his diagnosis spread, friends, neighbors, and even strangers wanted to help. A small committee of friends and ...